Literature DB >> 23804286

Bullous pemphigoid as pruritus in the elderly: a common presentation.

Christiaan V Bakker1, Jorrit B Terra, Hendri H Pas, Marcel F Jonkman.   

Abstract

IMPORTANCE: In the literature, patients with bullous pemphigoid have been reported to have itch without blisters. Clinical observations in these patients have varied from eczematous or urticarial to papular or nodular skin lesions. Here we investigated the spectrum of clinical variants. OBSERVATIONS: Fifteen patients with itch without blisters had immunopathologic findings of bullous pemphigoid. Mean age at diagnosis was 81.7 years. No blistering occurred during the mean 2.2 years of follow-up. Mean delay of diagnosis was 2.8 years. Clinical symptoms were heterogeneous: pruritus sine materia (no primary skin lesions), eczematous, urticarial, papular, and/or nodular skin lesions were seen. Treatment with potent topical corticosteroids or methotrexate sodium led to remission in 11 patients. CONCLUSIONS AND RELEVANCE: Itch without skin lesions can be the only symptom of bullous pemphigoid. Therefore, it is important to include serologic and direct immunofluorescence in the diagnostic algorithm of itch. We propose the unifying term pruritic nonbullous pemphigoid for all patients with immunopathologic findings of bullous pemphigoid, itch, and no blisters.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23804286     DOI: 10.1001/jamadermatol.2013.756

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  13 in total

1.  Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid.

Authors:  Joost M Meijer; Gilles F H Diercks; Emma W G de Lang; Hendri H Pas; Marcel F Jonkman
Journal:  JAMA Dermatol       Date:  2019-02-01       Impact factor: 10.282

Review 2.  [Pemphigoid diseases. Autoimmune diseases in the elderly].

Authors:  O N Horváth; J Jankásková; A Walker; M Sárdy
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

Review 3.  Promising Natural Products in New Drug Design, Development, and Therapy for Skin Disorders: An Overview of Scientific Evidence and Understanding Their Mechanism of Action.

Authors:  Nurul Amirah Mohd Zaid; Mahendran Sekar; Srinivasa Reddy Bonam; Siew Hua Gan; Pei Teng Lum; M Yasmin Begum; Nur Najihah Izzati Mat Rani; Jaishree Vaijanathappa; Yuan Seng Wu; Vetriselvan Subramaniyan; Neeraj Kumar Fuloria; Shivkanya Fuloria
Journal:  Drug Des Devel Ther       Date:  2022-01-06       Impact factor: 4.162

Review 4.  Itch: Epidemiology, clinical presentation, and diagnostic workup.

Authors:  Youkyung S Roh; Justin Choi; Nishadh Sutaria; Shawn G Kwatra
Journal:  J Am Acad Dermatol       Date:  2021-08-21       Impact factor: 11.527

Review 5.  Pruritus in Autoimmune and Inflammatory Dermatoses.

Authors:  Claudia Zeidler; Manuel Pedro Pereira; Flavien Huet; Laurent Misery; Kerstin Steinbrink; Sonja Ständer
Journal:  Front Immunol       Date:  2019-06-21       Impact factor: 7.561

6.  Clinical characteristics of pruritus in patients with bullous pemphigoid: a preliminary questionnaire-based study.

Authors:  Agnieszka Kalinska-Bienias; Emilia Kowalczyk; Pawel Jagielski; Anna Lesniewska; Aleksandra Komorowska; Cezary Kowalewski; Katarzyna Wozniak
Journal:  Postepy Dermatol Alergol       Date:  2021-01-06       Impact factor: 1.837

7.  Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders.

Authors:  Dario Didona; Luca Scarsella; Milad Fehresti; Farzan Solimani; Hazem A Juratli; Manuel Göbel; Stefan Mühlenbein; Lily Holiangu; Josquin Pieper; Vera Korff; Thomas Schmidt; Cassian Sitaru; Rüdiger Eming; Michael Hertl; Robert Pollmann
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

Review 8.  Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients' Assessment.

Authors:  Angelo Ruggiero; Matteo Megna; Alessia Villani; Rosita Comune; Gabriella Fabbrocini; Francesca di Vico
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-04-14

Review 9.  A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management.

Authors:  Adriana T Lopez; Larisa Geskin
Journal:  Oncologist       Date:  2018-07-17

Review 10.  The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease.

Authors:  Kyle T Amber; Manuel Valdebran; Khalaf Kridin; Sergei A Grando
Journal:  Front Med (Lausanne)       Date:  2018-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.